← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN ETHYLSUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 1980-04-28

Drug application

FDA Application #

ANDA062256

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN ETHYLSUCCINATE

Generic name

Erythromycin Ethylsuccinate

Active ingredients

ERYTHROMYCIN ETHYLSUCCINATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

BARR

First approval

1980-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown